Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs)
Selective norepinephrine reuptake inhibitors (SNRIs) are a type of antidepressant medication. They can also help treat anxiety, chronic pain, and the symptoms of fibromyalgia.
What Are SNRIs?
What Conditions Do SNRIs Treat?
- Major depressive disorder
- Generalized anxiety disorder
- Social anxiety disorder
- Panic disorder
- Pain due to diabetic neuropathy
- Fibromyalgia
- Chronic musculoskeletal pain
They might prescribe an SNRI off-label if you have:
- Hot flashes and night sweats due to menopause
- Peripheral neuropathy, or nerve pain, resulting from chemotherapy
- Urinary incontinence
- Attention deficit hyperactivity disorder (ADHD)
- Obsessive-compulsive disorder (OCD)
- Migraine
- Headache
Types of SNRIs
- desvenlafaxine (Pristiq)
- duloxetine (Cymbalta)
- milnacipran (Savella)
- venlafaxine (Effexor)
- levomilnacipran (Fetzima)
How Do SNRIs Work?
Serotonin is known as a “feel good” hormone, while norepinephrine boosts energy and alertness. SNRIs increase the levels of both of these hormones, which are also neurotransmitters that carry messages to different parts of the body.
Another class of drugs, SSRIs, also treat mood disorders like depression and other conditions by raising serotonin levels.
What Are the Possible Side Effects of SNRIs?
- Nausea and vomiting
- Dry mouth
- Constipation
- Fatigue
- Drowsiness
- Sexual dysfunction
- High blood pressure
- Headache
- Excessive sweating, known as diaphoresis
- Unusual bleeding or bruising
- Seizures, in rare cases
Are There Any Risks Related to SNRIs?
- Have kidney or liver problems
- Are pregnant or breastfeeding
- Use certain other drugs, such as anticoagulants
- Have narrow-angle glaucoma
- Have high blood pressure
- Are under 18 years old
Your doctor may not prescribe SNRIs if you already take:
- Other drugs that affect serotonin levels, such as SSRIs, lithium, or St John’s wort
- A (CYP) 3A4 inhibitor, such as amiodarone or ketoconazole
- Some weight loss agents
The Takeaway
Serotonin and norepinephrine reuptake inhibitors (SNRIs) are prescription drugs that treat depression, anxiety disorders, fibromyalgia, and other medical conditions. They do this by changing how neurotransmitters in the brain communicate with each other. They can also have adverse effects on mood, so your doctor can help you decide if an SNRI is suitable for you.

Angela D. Harper, MD
Medical Reviewer
Angela D. Harper, MD, is in private practice at Columbia Psychiatric Associates in South Carolina, where she provides evaluations, medication management, and psychotherapy for adul...

Yvette Brazier
Author
Yvette Brazier's career has focused on language, communication, and content production, particularly in health education and information. From 2005 to 2015, she supported learning ...
- Serotonin and norepinephrine reuptake inhibitors (SNRIs). Mayo Clinic. October 2019.
- Zhang Z et al. Depressive Symptoms and Mortality Among US Adults. JAMA Network Open. October 9, 2023.
- SNRIs (Serotonin and Norepinephrine Reuptake Inhibitors). Cleveland Clinic. May 2023.
- Brain hormones. The Endocrine Society. January 2022.
- Adrenal Hormones. The Endocrine Society. January 2022.
- Depression Medicines. Food and Drug Administration. November 2019.
- Sheffler ZM et al. Antidepressants. StatPearls. May 2023.
- Fornaro M et al. The FDA “Black Box” Warning on Antidepressant Suicide Risk in Young Adults: More Harm Than Benefits? Frontiers in Psychiatry. May 3, 2019.
- Laban TS et al. Monoamine Oxidase Inhibitors (MAOI). StatPearls. July 17, 2023.
- Label: VENLAFAXINE HYDROCHLORIDE capsule, extended release. National Library of Medicine Dailymed. March 2024.
- Label: CYMBALTA- duloxetine hydrochloride capsule, delayed release. National Library of Medicine Dailymed. August 2023.
- Label: SAVELLA- milnacipran hydrochloride tablet, film coated. National Library of Medicine Dailymed. July 2010.
- Label: FETZIMA- levomilnacipran hydrochloride capsule, extended release FETZIMA- levomilnacipran hydrochloride kit. National Library of Medicine Dailymed. April 2024.
- Label: DESVENLAFAXINE tablet, extended release. National Library of Medicine Dailymed. August 2023.
- Simon LV et al. Serotonin Syndrome. StatPearls. March 2024.